Asthma: pathophysiology of the bronchial obstruction. Maselli R,Paciocco G. Allergy . 2000Maselli R,Paciocco G.Asthma:pathophysiology of the bronchial obstruction.Allergy. 2000Maselli, R.; Paciocco, G. Asthma: Pathophysiology of the Bronchial Obstruction. Allergy 2000, 55 (Suppl. 61), 49-51....
The understanding of thepathophysiologyof asthma has advanced in the past decade. It is a condition of bronchial hyperactivity with the inflammatory component central to the pathogenesis of symptoms. Asthma is characterized by inflammation of the airways, with an abnormal accumulation ofinflammatory cells...
What is the pathophysiology of bronchial asthma? And what happens in the respiratory tubes when it occurs? Epithelial Tissues Diseases: Epithelial tissues are the cells that line body cavities, organs, and other surfaces. They provide a barrier between the body and...
4. Bronchial responsiveness 5. Airway inflammation 6. Development of airway remodeling Epidemiology of asthma Predictors of asthma severity may include disease duration, female gender, African American race, level of lung function, and degree of allergy. Although the need for hospitalization is also us...
Pathologically, asthma is a disease of airflow obstruction caused by combinations of bronchial smooth muscle contraction, mucosal edema and inflammation, and viscous mucin secretion. The disease involves large and small airways but not alveoli, and the processes leading to airflow obstruction are ...
Inhibition of acetylcholine-induced bronchoconstriction in asthmatics by nifedipine. The calcium-dependent constriction of bronchial smooth muscle cells and release of mediators derived from mast cells is important in the pathophysiology of... OC Burghuber,M Kneussl,P Harmuth,... - 《Respiration》 ...
Kleniewska, P., and R. Pawliczak. 2017. The participation of oxidative stress in the pathogenesis of bronchial asthma.Biomedicine & Pharmacotherapy94: 100–108. CASGoogle Scholar Bishopp, A., R. Sathyamurthy, S. Manney, C. Webbster, M.T. Krishna, and A.H. Mansur. 2017. Biomarkers ...
Bronchial asthma (BA) and obesity are one of the major modern problem, requiring the development of an effective therapeutic strategy. The frequent combina... O. Y. Kytikovа,T. Novgorodtseva,Y. K. Denisenko,... - 《Annals of the Russian Academy of Medical Sciences》 被引量: 0发表: ...
A major limitation to control of severe asthma is the recalcitrant response of these patients to usual therapy including systemic corticosteroids; the potential of other therapies was reviewed. From these discussions, recommendations were made for future research needs to gain insights into a difficult ...
Figure 2. Biologic therapy of bronchial asthma and other allergic disorders. Most of the current monoclonal antibodies and inhibitors target type 2 inflammation (registered biologics in blue letters). Anti – IgE therapy with omalizumab and ligelizumab is already very effective and safe approach to...